Processa Pharmaceuticals, Inc. Adjustments to Additional Paid in Capital, Other
Processa Pharmaceuticals, Inc. (PCSA) reported Adjustments to Additional Paid in Capital, Other of $312.29 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2021-11-12
- Processa Pharmaceuticals, Inc. adjustments to additional paid in capital, other for the quarter ending 2021-03-31 was $312.29K.
- Processa Pharmaceuticals, Inc. adjustments to additional paid in capital, other for the quarter ending 2020-09-30 was $197.40K.
- Processa Pharmaceuticals, Inc. adjustments to additional paid in capital, other for the quarter ending 2018-03-31 was $8.00M.
- Processa Pharmaceuticals, Inc. adjustments to additional paid in capital, other for fiscal 2018 was $8.00M.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|
| 2021-03-31 | $312.29K 10-Q · filed 2021-05-13 | |
| 2020-09-30 | $197.40K 10-Q · filed 2021-11-12 | |
| 2018-12-31 | $8.00M 10-K · filed 2020-03-06 | |
| 2018-03-31 | $8.00M 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |